Mouse-adapted SARS-CoV-2 model provides new tool for COVID-19 discoveries
CHAPEL HILL, N.C. – A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial. Researchers, among them virologists and microbiologists at UNC-Chapel Hill’s Gillings School of Global Public Health, describe the…